ONCOLOGY

Epigenetics and Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on Epigenetics and Cancer

Figure 5-1 Chromatin surrounding an actively expressed gene in a normal mature cell versus surrounding that same gene when it is DNA hypermethylated and aberrantly, heritably, silenced in a tumor…

read more

Thyroid Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on Thyroid Cancer

Figure 43-1 Schematic illustration of the key intracellular signaling pathways involved in the pathogenesis of differentiated thyroid carcinoma. Figure 43-2 Schematic illustration of the key intracellular signaling pathways involved in…

read more

Epithelial Skin Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on Epithelial Skin Cancer

In addition to these highly penetrant hereditary syndromes, genome-wide association studies are identifying new loci that confer increased risk for either BCC or SCC, although the mechanistic details remain. Single-nucleotide…

read more

Multiple Myeloma

Feb 15, 2017 by in ONCOLOGY Comments Off on Multiple Myeloma

Figure 30-1 An outline of the main factors leading from multiple myeloma (MM) to monoclonal gammopathy of undetermined significance (MGUS); the distinction between HD and NHD MM; and finally additional…

read more

The Molecular Pathogenesis of Head and Neck Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on The Molecular Pathogenesis of Head and Neck Cancer

Figure 33-1 The Field Cancerization Theory is defined as the presence of one or more mucosal areas consisting of epithelial cells with cancer-associated genetic or epigenetic alterations. A precursor field…

read more

Cancer Immunotherapy with Vaccines and Checkpoint Blockade

Feb 15, 2017 by in ONCOLOGY Comments Off on Cancer Immunotherapy with Vaccines and Checkpoint Blockade

html xmlns=”http://www.w3.org/1999/xhtml”> 52 Cancer Immunotherapy with Vaccines and Checkpoint Blockade Drew Pardoll Therapeutic vaccination for cancer continues to be a major approach to the overall immunotherapy of cancer. Historically, interest…

read more

Molecular Basis for Treating Cutaneous Melanoma

Feb 15, 2017 by in ONCOLOGY Comments Off on Molecular Basis for Treating Cutaneous Melanoma

Figure 42-1 Development of melanoma Although melanomas can develop from melanocytes at the epidermal-dermal junction directly or in a preexisting nevus, an orderly progression from melanocyte to neoplasm (benign nevus)…

read more

Cellular Senescence

Feb 15, 2017 by in ONCOLOGY Comments Off on Cellular Senescence

Figure 15-1 Senescence stimuli and biological characteristics Senescence is induced by diverse endogenous and exogenous stresses that promote strong pro-proliferative signaling and DNA damage responses. Senescent cells undergo a permanent…

read more

Tumor Suppressor Genes

Feb 15, 2017 by in ONCOLOGY Comments Off on Tumor Suppressor Genes

A third interpretation of the role of haploinsufficiency in tumorigenesis is based on the exquisite sensitivity of cells to even small changes in the levels of some cancer-associated proteins. Thus,…

read more

Interferons

Feb 15, 2017 by in ONCOLOGY Comments Off on Interferons

html xmlns=”http://www.w3.org/1999/xhtml”> 53 Interferons Ernest C. Borden ∗ Introduction Interferons (IFNs) comprise a family of secreted α-helical cytokines induced in response to specific extracellular biomolecules through stimulation of Toll-like receptors…

read more
Get Clinical Tree app for offline access